|
1
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the united states in 2008–2012. Neuro Oncol. 17
(Suppl 4):iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu CA, Chang CY, Hsueh KW, Su HL, Chiou
TW, Lin SZ and Harn HJ: Migration/invasion of malignant gliomas and
implications for therapeutic treatment. Int J Mol Sci. 19:11152018.
View Article : Google Scholar
|
|
3
|
Chatterjee A, Mambo E and Sidransky D:
Mitochondrial DNA mutations in human cancer. Oncogene.
25:4663–4674. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rocha EM, De Miranda B and Sanders LH:
Alpha-synuclein: Pathology, mitochondrial dysfunction and
neuroinflammation in Parkinson's disease. Neurobiol Dis.
109:249–257. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Verma P, Singh A, Nthenge-Ngumbau DN,
Rajamma U, Sinha S, Mukhopadhyay K and Mohanakumar KP: Attention
deficit-hyperactivity disorder suffers from mitochondrial
dysfunction. BBA Clin. 6:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kraya T, Deschauer M, Joshi PR, Zierz S
and Gaul C: Prevalence of headache in patients with mitochondrial
disease: A cross-sectional study. Headache. 58:45–52. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Szendroedi J, Phielix E and Roden M: The
role of mitochondria in insulin resistance and type 2 diabetes
mellitus. Nat Rev Endocrinol. 8:92–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Theurey P and Pizzo P: The aging
mitochondria. Genes (Basel). 9:222018. View Article : Google Scholar
|
|
9
|
Schapira AH: Mitochondrial disease.
Lancet. 368:70–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sharma P and Sampath H: Mitochondrial DNA
integrity: Role in health and disease. Cells. 8:1002019. View Article : Google Scholar
|
|
11
|
Dias N and Bailly C: Drugs targeting
mitochondrial functions to control tumor cell growth. Biochem
Pharmacol. 70:1–12. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Govindaraj P, Rani B, Sundaravadivel P,
Vanniarajan A, Indumathi KP, Khan NA, Dhandapany PS, Rani DS,
Tamang R, Bahl A, et al: Mitochondrial genome variations in
idiopathic dilated cardiomyopathy. Mitochondrion. 48:51–59. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spadafora D, Kozhukhar N, Chouljenko VN,
Kousoulas KG and Alexeyev MF: Methods for efficient elimination of
mitochondrial DNA from cultured cells. PLoS One. 11:e01546842016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Long Q, Liu J, Tang H, Li Y, Bao
F, Qin D, Pei D and Liu X: Mitochondrial fusion provides an
‘initial metabolic complementation’ controlled by mtDNA. Cell Mol
Life Sci. 72:2585–2598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chomyn A: Platelet-mediated transformation
of human mitochondrial DNA-less cells. Methods Enzymol.
264:334–339. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon YG, Oh YJ and Yoo YH: Rapid isolation
of mitochondrial DNA-depleted mammalian cells by ethidium bromide
and dideoxycytidine treatments. J App Biol Chem. 57:259–265. 2014.
View Article : Google Scholar
|
|
17
|
Yu M, Shi Y, Wei X, Yang Y, Zhou Y, Hao X,
Zhang N and Niu R: Depletion of mitochondrial DNA by ethidium
bromide treatment inhibits the proliferation and tumorigenesis of
T47D human breast cancer cells. Toxicol Lett. 170:83–93. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fernández-Moreno M, Hermida-Gómez T,
Gallardo ME, Dalmao-Fernández A, Rego-Pérez I, Garesse R and Blanco
FJ: Generating rho-0 cells using mesenchymal stem cell lines. PLoS
One. 11:e01641992016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Binder DR, Dunn WH Jr and Swerdlow RH:
Molecular characterization of mtDNA depleted and repleted NT2 cell
lines. Mitochondrion. 5:255–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kukat A, Kukat C, Brocher J, Schäfer I,
Krohne G, Trounce IA, Villani G and Seibel P: Generation of rho0
cells utilizing a mitochondrially targeted restriction endonuclease
and comparative analyses. Nucleic Acids Res. 36:e442008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Holmuhamedova E, Jahangira A,
Bienengraebera M, Lewisb LD and Terzic A: Deletion of mtDNA
disrupts mitochondrial function and structure, but not biogenesis.
Mitochondrion. 3:13–19. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alston CL, Rocha MC, Lax NZ, Turnbull DM
and Taylor RW: The genetics and pathology of mitochondrial disease.
J Pathol. 241:236–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meiliana A, Dewi NM and Wijaya A:
Mitochondria in health and disease. Indonesian Biomedical J.
11:1–15. 2019. View Article : Google Scholar
|
|
24
|
Miller SW, Trimmer PA, Davis Parker W Jr
and Davis RE: Creation and characterization of mitochondrial
DNA-depleted cell lines with ‘neuronal-like’ properties. J
Neurochem. 67:1897–1907. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Desjardins P, Frost E and Morais R:
Ethidium bromide-induced loss of mitochondrial DNA from primary
chicken embryo fibroblasts. Mol Cell Biol. 5:1163–1169. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Armand R, Channon JY, Kintner J, White KA,
Miselis KA, Perez RP and Lewis LD: The effects of ethidium bromide
induced loss of mitochondrial DNA on mitochondrial phenotype and
ultrastructure in a human leukemia T-cell line (MOLT-4 cells).
Toxicol Appl Pharmacol. 196:68–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nelson I, Hanna MG, Wood NW and Harding
AE: Depletion of mitochondrial DNA by ddC in untransformed human
cell lines. Somat Cell Mol Genet. 23:287–290. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
King MP and Attardi G: Isolation of human
cell lines lacking mitochondrial DNA. Methods Enzymol. 264:304–313.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wochna A, Niemczyk E, Kurono C, Masaoka M,
Majczak A, Kedzior J, Slominska E, Lipinski M and Wakabayashi T:
Role of mitochondria in the switch mechanism of the cell death mode
from apoptosis to necrosis-studies on rho0 cells. J Electron
Microsc (Tokyo). 54:127–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schauen M, Spitkovsky D, Schubert J,
Fischer JH, Hayashi J and Wiesner RJ: Respiratory chain deficiency
slows down cell-cycle progression via reduced ROS generation and is
associated with a reduction of p21CIP1/WAF1. J Cell Physiol.
209:103–112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Inoue K, Takai D, Hosaka H, Ito S, Shitara
H, Isobe K, LePecq JB, Segal-Bendirdjian E and Hayashi J: Isolation
and characterization of mitochondrial DNA-less lines from various
mammalian cell lines by application of an anticancer drug,
ditercalinium. Biochem Biophys Res Commun. 239:257–260. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tomita K, Kuwahara Y, Takashi Y, Tsukahara
T, Kurimasa A, Fukumoto M, Nishitani Y and Sato T: Sensitivity of
mitochondrial DNA depleted ρ0 cells to H2O2
depends on the plasma membrane status. Biochem Biophys Res Commun.
490:330–335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Boland ML, Chourasia AH and Macleod KF:
Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vyas S, Zaganjor E and Haigis MC:
Mitochondria and Cancer. Cell. 166:555–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Penrose HM, Heller S, Cable C, Nakhoul H,
Ungerleider N, Baddoo M, Pursell ZF, Flemington EK, Crawford SE and
Savkovic SD: In colonic ρ° (rho0) cells reduced mitochondrial
function. Oncoscience. 4:189–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pessôa LVF, Bressan FF, Chiaratti MR,
Pires PR, Perecin F, Smith LC and Meirelles FV: Mitochondrial DNA
dynamics during in vitro culture and pluripotency induction of a
bovine Rho0 cell line. Genet Mol Res. 14:14093–14104. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mei H, Sun S, Bai Y, Chen Y, Chai R and Li
H: Reduced mtDNA copy number increases the sensitivity of tumor
cells to chemotherapeutic drugs. Cell Death Dis. 6:e17102015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zong WX, Rabinowitz JD and White E:
Mitochondria and cancer. Mol Cell. 61:667–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grady JP, Pickett SJ, Ng YS, Alston CL,
Blakely EL, Hardy SA, Feeney CL, Bright AA, Schaefer AM, Gorman GS,
et al: mtDNA heteroplasmy level and copy number indicate disease
burden in m.3243A>G mitochondrial disease. EMBO Mol Med.
10:e82622018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Márquez-Jurado S, Díaz-Colunga J, das
Neves RP, Martinez-Lorente A, Almazán F, Guantes R and Iborra FJ:
Mitochondrial levels determine variability in cell death by
modulating apoptotic gene expression. Nat Commun. 9:3892018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Papal S and Skulachev VP: Reactive oxygen
species, mitochondria, apoptosis and aging. Mol Cell Biochem.
174:305–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Frazier AE, Thorburn DR and Compton AG:
Mitochondrial energy generation disorders: Genes, mechanisms, and
clues to pathology. J Biol Chem. 294:5386–5395. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shadel GS and Horvath TL: Mitochondrial
ROS signaling in organismal homeostasis. Cell. 163:560–569. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nunnari J and Suomalainen A: Mitochondria:
In sickness and in health. Cell. 148:1145–1159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Meyer JN, Hartman JH and Mello DF:
Mitochondrial toxicity. Toxicol Sci. 162:15–23. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ristow M, Zarse K, Oberbach A, Klöting N,
Birringer M, Kiehntopf M, Stumvoll M, Kahn CR and Blüher M:
Antioxidants prevent health-promoting effects of physical exercise
in humans. Proc Natl Acad Sci USA. 106:8665–8670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Buchet K and Godinot C: Functional
F1-ATPase essential in maintaining growth and membrane potential of
human mitochondrial DNA-depleted rho degrees cells. J Biol Chem.
273:22983–22989. 1998. View Article : Google Scholar : PubMed/NCBI
|
